ALG11 is an endoplasmic reticulum membrane alpha-1,2-mannosyltransferase (EC 2.4.1.131) of the dolichol-linked oligosaccharide (LLO) assembly pathway. Using GDP-mannose as donor, it adds the fourth and fifth mannose residues onto Man3GlcNAc2-PP-dolichol to produce Man5GlcNAc2-PP-dolichol, the final cytoplasmic-face LLO intermediate; this glycan is then flipped into the ER lumen (by RFT1) for continued assembly and eventual transfer to nascent proteins during protein N-linked glycosylation. It is a single-pass ER membrane protein whose catalytic domain faces the cytosol and belongs to the glycosyltransferase group 1 family (GT4 subfamily). Loss of function causes ALG11-CDG (congenital disorder of glycosylation type Ip), a multisystem disorder with under-glycosylated serum glycoproteins.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0004377
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred core molecular function. This is the exact biochemical activity ALG11 catalyzes and is directly supported by experimental characterization in human cells.
Reason: Core molecular function of ALG11. The IBA is concordant with the human IDA (PMID:20080937) and with the UniProt-curated catalytic activity (EC 2.4.1.131).
Supporting Evidence:
PMID:20080937
caused by the deficiency of GDP-Man:Man3GlcNAc2-PP-dolichol-alpha1,2-mannosyltransferase, encoded by the
file:human/ALG11/ALG11-uniprot.txt
Catalyzes, on
CC the cytoplasmic face of the endoplasmic reticulum, the addition of the
CC fourth and fifth mannose residues
|
|
GO:0006488
dolichol-linked oligosaccharide biosynthetic process
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred participation in dolichol-linked oligosaccharide (LLO) biosynthesis, the pathway in which ALG11 adds the fourth and fifth mannoses to Man3GlcNAc2-PP-dolichol.
Reason: Core biological process. Concordant with the human IMP (PMID:20080937), where patient fibroblasts accumulate the LLO intermediates upstream of the ALG11 step.
Supporting Evidence:
PMID:20080937
accumulation of Man3GlcNAc2-PP-dolichol and Man4GlcNAc2-PP-dolichol
|
|
GO:0005789
endoplasmic reticulum membrane
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred site of action at the ER membrane, where LLO assembly occurs on the cytoplasmic face.
Reason: Core cellular component. Concordant with UniProt subcellular location and the human IDA localization study (PMID:20080937).
Supporting Evidence:
file:human/ALG11/ALG11-uniprot.txt
SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
|
|
GO:0004377
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Automated electronic inference of the same core catalytic activity from InterPro, RHEA:29523 and EC:2.4.1.131 mappings.
Reason: Correct and specific. The RHEA/EC mapping matches the experimentally verified reaction, and this is the core molecular function.
Supporting Evidence:
file:human/ALG11/ALG11-uniprot.txt
EC=2.4.1.131 {ECO:0000269|PubMed:20080937}
|
|
GO:0005789
endoplasmic reticulum membrane
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Automated electronic inference of ER membrane localization from the UniProt Subcellular Location keyword mapping.
Reason: Correct core localization, consistent with curated UniProt location and experimental IDA.
Supporting Evidence:
file:human/ALG11/ALG11-uniprot.txt
SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
|
|
GO:0016757
glycosyltransferase activity
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: InterPro (IPR001296, Glyco_trans_1) domain-based inference of a general glycosyltransferase activity.
Reason: Correct but a broad parent of the specific mannosyltransferase activity (GO:0004377). Acceptable as a domain-level IEA that is legitimately more general than the experimentally supported term; not misleading.
Supporting Evidence:
file:human/ALG11/ALG11-uniprot.txt
Belongs to the glycosyltransferase group 1 family
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: Single high-throughput affinity-purification mass spectrometry (BioPlex) interaction with GLA (alpha-galactosidase A, P06280). Bare "protein binding" is uninformative about ALG11's molecular function.
Reason: The IPI derives from a proteome-scale AP-MS screen and captures a physical co-purification rather than a characterized functional interaction; the term "protein binding" adds no information about ALG11's actual mannosyltransferase function. Retained (not removed) per curation policy for experimental IPIs, but flagged as over-annotation.
Supporting Evidence:
PMID:33961781
affinity purification
of 10,128 human proteins-half the proteome-in 293T cells
|
|
GO:0006488
dolichol-linked oligosaccharide biosynthetic process
|
IMP
PMID:20080937 A severe human metabolic disease caused by deficiency of the... |
ACCEPT |
Summary: Human mutant-phenotype evidence (patient with p.L86S) for a role in LLO biosynthesis; patient fibroblasts accumulate Man3GlcNAc2-PP-dolichol/Man4GlcNAc2-PP-dolichol and are deficient in elongating Man3GlcNAc2-PP-dolichol.
Reason: Directly supported core biological process; the phenotype pinpoints the ALG11 step in LLO assembly, and complementation with WT hALG11 rescued it.
Supporting Evidence:
PMID:20080937
deficient in elongating Man3GlcNAc2-PP-dolichol
|
|
GO:0004377
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity
|
IDA
PMID:20080937 A severe human metabolic disease caused by deficiency of the... |
ACCEPT |
Summary: Direct assay of ALG11 mannosyltransferase activity in human fibroblasts; the CDG1P p.L86S variant decreases this activity, establishing the catalytic function experimentally.
Reason: Core molecular function with direct experimental support. This is the exact GOA molecular-function term used in core_functions.
Supporting Evidence:
PMID:20080937
caused by the deficiency of GDP-Man:Man3GlcNAc2-PP-dolichol-alpha1,2-mannosyltransferase, encoded by the
file:human/ALG11/ALG11-uniprot.txt
EC=2.4.1.131 {ECO:0000269|PubMed:20080937}
|
|
GO:0005789
endoplasmic reticulum membrane
|
IDA
PMID:20080937 A severe human metabolic disease caused by deficiency of the... |
ACCEPT |
Summary: Immunofluorescence localization of ALG11 to the ER in control and patient fibroblasts; the p.L86S variant does not mislocalize the protein.
Reason: Directly supported core cellular component. The localization study confirms ER membrane residence and shows the disease variant retains normal localization.
Supporting Evidence:
PMID:20080937
indicating no mislocalization or
file:human/ALG11/ALG11-uniprot.txt
SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
|
|
GO:0006487
protein N-linked glycosylation
|
IMP
PMID:20080937 A severe human metabolic disease caused by deficiency of the... |
ACCEPT |
Summary: Human mutant-phenotype evidence for a role in protein N-linked glycosylation; the patient shows partial loss of complete N-glycan side chains (serum transferrin hypoglycosylation, a CDG-I signature).
Reason: Core biological process. ALG11 builds the LLO precursor that is ultimately transferred to asparagine residues; its deficiency causes the underglycosylation phenotype diagnostic of CDG-I.
Supporting Evidence:
PMID:20080937
the partial loss of complete N-glycan
|
|
GO:0000026
alpha-1,2-mannosyltransferase activity
|
TAS
Reactome:R-HSA-4551297 |
ACCEPT |
Summary: Reactome author-statement annotation to the general alpha-1,2-mannosyltransferase activity, the parent of the specific ALG11 activity term.
Reason: Correct but a less-specific parent of GO:0004377. Retained as an accurate (if more general) molecular-function annotation from a reliable TAS source.
Supporting Evidence:
Reactome:R-HSA-4551297
transfers the fourth and fifth mannoses (Man) to the N-glycan precursor in an alpha-1,2 orientation
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-4551297 |
ACCEPT |
Summary: Reactome author-statement localization of ALG11 to the ER membrane, where it acts on the cytosolic face during LLO assembly.
Reason: Correct core cellular component, concordant with the IDA and IBA evidence.
Supporting Evidence:
Reactome:R-HSA-4551297
These additions are the last two on the cytosolic side of the ER membrane
|
|
GO:0016020
membrane
|
HDA
PMID:19946888 Defining the membrane proteome of NK cells. |
MARK AS OVER ANNOTATED |
Summary: High-throughput mass-spectrometry detection of ALG11 in a membrane-proteome survey of the YTS NK-like cell line. Generic "membrane" localization.
Reason: A proteome-scale membrane-fraction survey (ALG11 was not the study subject) supporting only the very general term "membrane", which is subsumed by the specific and well-supported "endoplasmic reticulum membrane". Retained but flagged as over-annotation.
Supporting Evidence:
PMID:19946888
identified 1843 proteins with high confidence
|
UniProt: Q2TAA5 (ALG11_HUMAN). HGNC:32456. Gene synonym GT8. EC 2.4.1.131.
ALG11 is the ER alpha-1,2-mannosyltransferase of the dolichol-linked oligosaccharide
(LLO) assembly pathway. It uses GDP-mannose as the sugar donor and adds the fourth and
fifth mannose residues onto Man3GlcNAc2-PP-dolichol, producing Man5GlcNAc2-PP-dolichol,
the final cytoplasmic-face LLO intermediate. These are the last two mannose additions on the
cytosolic side of the ER membrane before the glycan is flipped into the ER lumen by RFT1.
The Man5GlcNAc2-PP-dolichol product is then the substrate for ALG3 (next enzyme).
Deficiency causes ALG11-CDG (congenital disorder of glycosylation type Ip / CDG1P; MIM:613661).
PMID:20080937 (Rind et al. 2010): homozygous c.T257C (p.L86S), patient fibroblasts accumulate
Man3GlcNAc2-PP-dolichol and Man4GlcNAc2-PP-dolichol, deficient in elongating
Man3GlcNAc2-PP-dolichol; retroviral rescue with WT hALG11 and yeast alg11-delta complementation
confirmed causality. Multisystem disorder (hypotonia, seizures, developmental retardation).
Additional CDG1P variants Y279S, Q318P, L381S, E398K (PMID:22213132, Thiel et al. 2012 — not cached).
MF GO:0004377 (GDP-Man:Man(3)GlcNAc(2)-PP-Dol a-1,2-MT activity): IBA, IEA, IDA -> ACCEPT (core MF;
IDA in PMID:20080937 characterises activity, L86S reduces it). This is the exact GOA MF term used
in core_functions.
BP GO:0006488 (dolichol-linked oligosaccharide biosynthetic process): IBA + IMP -> ACCEPT (core BP).
BP GO:0006487 (protein N-linked glycosylation): IMP -> ACCEPT (core BP; LLO precursor feeds N-glyc).
CC GO:0005789 (ER membrane): IBA, IEA, IDA, TAS -> ACCEPT (core CC; IDA localization in patient/control fibroblasts).
MF GO:0016757 (glycosyltransferase activity): IEA InterPro -> ACCEPT (correct but general parent; IEA allowed broader).
MF GO:0000026 (alpha-1,2-mannosyltransferase activity): TAS Reactome -> ACCEPT (correct less-specific parent).
MF GO:0005515 (protein binding): IPI, PMID:33961781 BioPlex, with P06280/GLA -> MARK_AS_OVER_ANNOTATED
(bare, uninformative; single high-throughput AP-MS pull-down; not a functional interaction).
CC GO:0016020 (membrane): HDA, PMID:19946888 -> MARK_AS_OVER_ANNOTATED (generic; ALG11 not the subject,
YTS NK-cell membrane-proteome MS survey; superseded by specific ER membrane).
id: Q2TAA5
gene_symbol: ALG11
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: ALG11 is an endoplasmic reticulum membrane alpha-1,2-mannosyltransferase
(EC 2.4.1.131) of the dolichol-linked oligosaccharide (LLO) assembly pathway. Using
GDP-mannose as donor, it adds the fourth and fifth mannose residues onto Man3GlcNAc2-PP-dolichol
to produce Man5GlcNAc2-PP-dolichol, the final cytoplasmic-face LLO intermediate;
this glycan is then flipped into the ER lumen (by RFT1) for continued assembly and
eventual transfer to nascent proteins during protein N-linked glycosylation. It
is a single-pass ER membrane protein whose catalytic domain faces the cytosol and
belongs to the glycosyltransferase group 1 family (GT4 subfamily). Loss of function
causes ALG11-CDG (congenital disorder of glycosylation type Ip), a multisystem disorder
with under-glycosylated serum glycoproteins.
existing_annotations:
- term:
id: GO:0004377
label: GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: Phylogenetically inferred core molecular function. This is the exact
biochemical activity ALG11 catalyzes and is directly supported by experimental
characterization in human cells.
action: ACCEPT
reason: Core molecular function of ALG11. The IBA is concordant with the human
IDA (PMID:20080937) and with the UniProt-curated catalytic activity (EC 2.4.1.131).
supported_by:
- reference_id: PMID:20080937
supporting_text: caused by the deficiency of
GDP-Man:Man3GlcNAc2-PP-dolichol-alpha1,2-mannosyltransferase, encoded by the
- reference_id: file:human/ALG11/ALG11-uniprot.txt
supporting_text: "Catalyzes, on\nCC the cytoplasmic face of the endoplasmic\
\ reticulum, the addition of the\nCC fourth and fifth mannose residues"
- term:
id: GO:0006488
label: dolichol-linked oligosaccharide biosynthetic process
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: Phylogenetically inferred participation in dolichol-linked oligosaccharide
(LLO) biosynthesis, the pathway in which ALG11 adds the fourth and fifth mannoses
to Man3GlcNAc2-PP-dolichol.
action: ACCEPT
reason: Core biological process. Concordant with the human IMP (PMID:20080937),
where patient fibroblasts accumulate the LLO intermediates upstream of the ALG11
step.
supported_by:
- reference_id: PMID:20080937
supporting_text: accumulation of Man3GlcNAc2-PP-dolichol and Man4GlcNAc2-PP-dolichol
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: is_active_in
review:
summary: Phylogenetically inferred site of action at the ER membrane, where LLO
assembly occurs on the cytoplasmic face.
action: ACCEPT
reason: Core cellular component. Concordant with UniProt subcellular location
and the human IDA localization study (PMID:20080937).
supported_by:
- reference_id: file:human/ALG11/ALG11-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Endoplasmic reticulum membrane'
- term:
id: GO:0004377
label: GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: Automated electronic inference of the same core catalytic activity from
InterPro, RHEA:29523 and EC:2.4.1.131 mappings.
action: ACCEPT
reason: Correct and specific. The RHEA/EC mapping matches the experimentally verified
reaction, and this is the core molecular function.
supported_by:
- reference_id: file:human/ALG11/ALG11-uniprot.txt
supporting_text: EC=2.4.1.131 {ECO:0000269|PubMed:20080937}
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: Automated electronic inference of ER membrane localization from the UniProt
Subcellular Location keyword mapping.
action: ACCEPT
reason: Correct core localization, consistent with curated UniProt location and
experimental IDA.
supported_by:
- reference_id: file:human/ALG11/ALG11-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Endoplasmic reticulum membrane'
- term:
id: GO:0016757
label: glycosyltransferase activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: InterPro (IPR001296, Glyco_trans_1) domain-based inference of a general
glycosyltransferase activity.
action: ACCEPT
reason: Correct but a broad parent of the specific mannosyltransferase activity
(GO:0004377). Acceptable as a domain-level IEA that is legitimately more general
than the experimentally supported term; not misleading.
supported_by:
- reference_id: file:human/ALG11/ALG11-uniprot.txt
supporting_text: Belongs to the glycosyltransferase group 1 family
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
qualifier: enables
review:
summary: Single high-throughput affinity-purification mass spectrometry (BioPlex)
interaction with GLA (alpha-galactosidase A, P06280). Bare "protein binding"
is uninformative about ALG11's molecular function.
action: MARK_AS_OVER_ANNOTATED
reason: The IPI derives from a proteome-scale AP-MS screen and captures a physical
co-purification rather than a characterized functional interaction; the term
"protein binding" adds no information about ALG11's actual mannosyltransferase
function. Retained (not removed) per curation policy for experimental IPIs, but
flagged as over-annotation.
supported_by:
- reference_id: PMID:33961781
supporting_text: "affinity purification \nof 10,128 human proteins-half the proteome-in\
\ 293T cells"
- term:
id: GO:0006488
label: dolichol-linked oligosaccharide biosynthetic process
evidence_type: IMP
original_reference_id: PMID:20080937
qualifier: involved_in
review:
summary: Human mutant-phenotype evidence (patient with p.L86S) for a role in LLO
biosynthesis; patient fibroblasts accumulate Man3GlcNAc2-PP-dolichol/Man4GlcNAc2-PP-dolichol
and are deficient in elongating Man3GlcNAc2-PP-dolichol.
action: ACCEPT
reason: Directly supported core biological process; the phenotype pinpoints the
ALG11 step in LLO assembly, and complementation with WT hALG11 rescued it.
supported_by:
- reference_id: PMID:20080937
supporting_text: deficient in elongating Man3GlcNAc2-PP-dolichol
- term:
id: GO:0004377
label: GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity
evidence_type: IDA
original_reference_id: PMID:20080937
qualifier: enables
review:
summary: Direct assay of ALG11 mannosyltransferase activity in human fibroblasts;
the CDG1P p.L86S variant decreases this activity, establishing the catalytic
function experimentally.
action: ACCEPT
reason: Core molecular function with direct experimental support. This is the
exact GOA molecular-function term used in core_functions.
supported_by:
- reference_id: PMID:20080937
supporting_text: caused by the deficiency of
GDP-Man:Man3GlcNAc2-PP-dolichol-alpha1,2-mannosyltransferase, encoded by the
- reference_id: file:human/ALG11/ALG11-uniprot.txt
supporting_text: EC=2.4.1.131 {ECO:0000269|PubMed:20080937}
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: IDA
original_reference_id: PMID:20080937
qualifier: is_active_in
review:
summary: Immunofluorescence localization of ALG11 to the ER in control and patient
fibroblasts; the p.L86S variant does not mislocalize the protein.
action: ACCEPT
reason: Directly supported core cellular component. The localization study confirms
ER membrane residence and shows the disease variant retains normal localization.
supported_by:
- reference_id: PMID:20080937
supporting_text: indicating no mislocalization or
- reference_id: file:human/ALG11/ALG11-uniprot.txt
supporting_text: 'SUBCELLULAR LOCATION: Endoplasmic reticulum membrane'
- term:
id: GO:0006487
label: protein N-linked glycosylation
evidence_type: IMP
original_reference_id: PMID:20080937
qualifier: involved_in
review:
summary: Human mutant-phenotype evidence for a role in protein N-linked glycosylation;
the patient shows partial loss of complete N-glycan side chains (serum transferrin
hypoglycosylation, a CDG-I signature).
action: ACCEPT
reason: Core biological process. ALG11 builds the LLO precursor that is ultimately
transferred to asparagine residues; its deficiency causes the underglycosylation
phenotype diagnostic of CDG-I.
supported_by:
- reference_id: PMID:20080937
supporting_text: the partial loss of complete N-glycan
- term:
id: GO:0000026
label: alpha-1,2-mannosyltransferase activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-4551297
qualifier: enables
review:
summary: Reactome author-statement annotation to the general alpha-1,2-mannosyltransferase
activity, the parent of the specific ALG11 activity term.
action: ACCEPT
reason: Correct but a less-specific parent of GO:0004377. Retained as an accurate
(if more general) molecular-function annotation from a reliable TAS source.
supported_by:
- reference_id: Reactome:R-HSA-4551297
supporting_text: transfers the fourth and fifth mannoses (Man) to the N-glycan
precursor in an alpha-1,2 orientation
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-4551297
qualifier: located_in
review:
summary: Reactome author-statement localization of ALG11 to the ER membrane, where
it acts on the cytosolic face during LLO assembly.
action: ACCEPT
reason: Correct core cellular component, concordant with the IDA and IBA evidence.
supported_by:
- reference_id: Reactome:R-HSA-4551297
supporting_text: These additions are the last two on the cytosolic side of the
ER membrane
- term:
id: GO:0016020
label: membrane
evidence_type: HDA
original_reference_id: PMID:19946888
qualifier: located_in
review:
summary: High-throughput mass-spectrometry detection of ALG11 in a membrane-proteome
survey of the YTS NK-like cell line. Generic "membrane" localization.
action: MARK_AS_OVER_ANNOTATED
reason: A proteome-scale membrane-fraction survey (ALG11 was not the study subject)
supporting only the very general term "membrane", which is subsumed by the specific
and well-supported "endoplasmic reticulum membrane". Retained but flagged as
over-annotation.
supported_by:
- reference_id: PMID:19946888
supporting_text: identified 1843 proteins with high confidence
core_functions:
- description: Alpha-1,2-mannosyltransferase that adds the fourth and fifth mannose
residues from GDP-mannose onto Man3GlcNAc2-PP-dolichol, producing Man5GlcNAc2-PP-dolichol
on the cytoplasmic face of the ER membrane, as part of dolichol-linked oligosaccharide
assembly for protein N-linked glycosylation.
molecular_function:
id: GO:0004377
label: GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity
directly_involved_in:
- id: GO:0006488
label: dolichol-linked oligosaccharide biosynthetic process
locations:
- id: GO:0005789
label: endoplasmic reticulum membrane
supported_by:
- reference_id: PMID:20080937
supporting_text: caused by the deficiency of
GDP-Man:Man3GlcNAc2-PP-dolichol-alpha1,2-mannosyltransferase, encoded by the
- reference_id: file:human/ALG11/ALG11-uniprot.txt
supporting_text: "Catalyzes, on\nCC the cytoplasmic face of the endoplasmic\
\ reticulum, the addition of the\nCC fourth and fifth mannose residues"
- description: Through building the Man5GlcNAc2-PP-dolichol LLO intermediate, ALG11
contributes to protein N-linked glycosylation; its deficiency causes hypoglycosylation
of serum glycoproteins (ALG11-CDG / CDG type Ip).
molecular_function:
id: GO:0004377
label: GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity
directly_involved_in:
- id: GO:0006487
label: protein N-linked glycosylation
locations:
- id: GO:0005789
label: endoplasmic reticulum membrane
supported_by:
- reference_id: PMID:20080937
supporting_text: the partial loss of complete N-glycan
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:19946888
title: Defining the membrane proteome of NK cells.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: High-throughput membrane-proteome MS survey of YTS NK-like cells;
ALG11 detected in the membrane fraction. Correctly cited for a generic HDA membrane
annotation but contributes no functional insight and is subsumed by the specific
ER membrane annotations.
- id: PMID:20080937
title: A severe human metabolic disease caused by deficiency of the endoplasmatic
mannosyltransferase hALG11 leads to congenital disorder of glycosylation-Ip.
findings:
- statement: Deficiency of human ALG11 (GDP-Man:Man3GlcNAc2-PP-dolichol alpha-1,2-mannosyltransferase)
causes CDG-Ip; patient fibroblasts accumulate Man3GlcNAc2-PP-dolichol and Man4GlcNAc2-PP-dolichol
and are deficient in elongating Man3GlcNAc2-PP-dolichol.
supporting_text: accumulation of Man3GlcNAc2-PP-dolichol and Man4GlcNAc2-PP-dolichol
- statement: The homozygous p.L86S variant reduces enzyme activity without altering
ER localization; causality confirmed by rescue with WT hALG11 and yeast alg11-delta
complementation.
supporting_text: indicating no mislocalization or
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Primary paper establishing ALG11 catalytic activity, LLO-pathway
role, ER localization and disease (CDG-Ip). Cache is abstract-only but the abstract
directly supports the MF, BP and CC annotations; PubMed-verified.
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: BioPlex proteome-scale AP-MS interactome study; source of the ALG11
IPI to GLA (P06280). Correctly cited but the interaction is a high-throughput
co-purification supporting only bare "protein binding".
- id: Reactome:R-HSA-4551297
title: Defective ALG11 does not transfer Man to the N-glycan precursor
findings:
- statement: ALG11 transfers the fourth and fifth mannoses to the N-glycan precursor
in an alpha-1,2 orientation, the last two additions on the cytosolic side of
the ER membrane before the glycan is flipped to the ER lumen.
supporting_text: transfers the fourth and fifth mannoses (Man) to the N-glycan
precursor in an alpha-1,2 orientation
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Reactome reaction describing the ALG11 step and its loss-of-function
disease (CDG-1p). Title left exactly as fetched.